DeLong Mark Jeffrey

Chief Business & Strat Officer

Officer

Latest Insider Transactions

Showing 10 of 22 transactions (past 365 days)

APLS
CB&SO
Disposition
$1.6M
82,500 shares @ $19.39
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$965.4K
27,224 shares @ $35.46
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$831.2K
18,750 shares @ $44.33
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$1.3M
30,000 shares @ $44.90
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$327.6K
6,952 shares @ $47.12
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$1.6M
30,845 shares @ $52.66
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$1.6M
24,666 shares @ $66.30
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Tender Special
$0
114,591 shares @ $0.00
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$0
41,250 shares @ $0.00
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.
APLS
CB&SO
Disposition
$205K
14,799 shares @ $13.85
Filed 2026-05-14Trade 2026-05-14
Apellis Pharmaceuticals, Inc.

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.